同有科技(300302.SZ):2024年淨虧損2.81億元
格隆匯4月28日丨同有科技(300302.SZ)發佈2024年年度報告,報告期內,公司實現營業收入3.65億元,同比增長3.89%,其中公司近年大力投入研發資源的存儲系統業務已成爲驅動公司業績增長的主要因素,本報告期存儲系統業務收入爲25,407.20萬元,同比增長109.33%;2024年公司發佈自主可控存儲系統高端新品,有效提升產品競爭力,驅動報告期公司綜合毛利率實現41.61%的較高水平;但是由於報告期內公司計提商譽減值25,593.70萬元,導致2024年度合併淨利潤爲-28,065.40萬元,剔除商譽減值各年影響因素後的公司2024年度淨利潤較2023年度同比減虧8,050.58萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.